The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 105,473 | 109,790 | 311,746 | - |
| Employee compensation and benefits | 25,407 | 24,036 | 74,213 | - |
| Engineering consulting costs | 7,597 | 7,816 | 20,113 | - |
| Administrative allocations | 5,163 | 4,731 | 13,315 | - |
| All other costs | 4,419 | 6,253 | 13,828 | - |
| Total cost of revenue, adjusted | 42,586 | 42,836 | 121,469 | - |
| Sales and marketing, adjusted | 37,789 | 40,362 | 107,218 | - |
| General and administrative, adjusted | 15,689 | 15,319 | 46,365 | - |
| Research and development, adjusted | 545 | - | - | - |
| Stock-based compensation expense | 2,661 | 2,710 | 8,361 | - |
| Depreciation and amortization expense | 995 | 1,022 | 2,839 | - |
| Reorganization costs | 407 | 2,555 | 1,936 | - |
| Litigation costs and related recoveries, net | 0 | -21 | 31,386 | - |
| Interest expense | 1,251 | 1,401 | 4,750 | - |
| Other (income) expenses, net | -1,240 | 187 | 1,686 | - |
| Income taxes | 949 | 3,027 | 15,506 | - |
| Net income | 1,361 | 724 | 2,766 | 33,608 |
| Stock-based compensation expense | 2,661 | 2,710 | 2,786 | 5,575 |
| Depreciation and amortization | 995 | 1,022 | 1,050 | 1,789 |
| Accretion and amortization of debt discount and issuance costs | 162 | 166 | 165 | 326 |
| Deferred income taxes | -1,450 | 1,457 | -920 | 10,628 |
| Amortization and accretion related to operating right of use assets | -1,350 | -1,363 | -1,276 | -2,421 |
| Other | -31 | -18 | -26 | - |
| Accounts receivable, net | -41,369 | 54,816 | -19,221 | -31,080 |
| Prepaid expenses, deposits and other | 2,833 | 3,074 | -35,722 | 42,620 |
| Deferred contract costs | -513 | 3,329 | 2,043 | -2,362 |
| Accounts payable | -779 | 1,097 | -1,328 | 675 |
| Accrued compensation and other accruals | -8,604 | 7,937 | 2,305 | -6,602 |
| Deferred revenue | -10,253 | 64,287 | -36,304 | -23,305 |
| Net cash provided by operating activities | 24,523 | 19,562 | 24,722 | 15,937 |
| Payment for purchases of short-term investments | - | 0 | 0 | 0 |
| Proceeds from sales and maturities of short-term investments | - | 0 | 0 | 0 |
| Capital expenditures | 648 | 706 | 1,204 | 2,661 |
| Net cash used in investing activities | -648 | -706 | -1,204 | -2,661 |
| Proceeds from issuance of 2024 credit facilitys term loan | - | 0 | - | - |
| Proceeds from the 2024 credit facilitys revolving line of credit | - | 0 | 0 | 0 |
| Principal payments on revolving line of credit borrowings | - | 0 | 10,000 | 5,000 |
| Principal payments on term loan borrowings | 10,938 | 937 | 938 | 1,875 |
| Payments to repurchase and retire common stock | - | 3,825 | 3,767 | - |
| Principal payments on capital leases | 0 | 33 | 98 | 191 |
| Proceeds from exercise of employee stock options | 337 | 4 | 50 | 9 |
| Net cash used in financing activities | -10,601 | -4,791 | -14,753 | -7,057 |
| Effect of foreign currency translation changes | -1,059 | -2,891 | -1,326 | 7,046 |
| Net change in cash, cash equivalents and restricted cash | 12,215 | 11,174 | 7,439 | 13,265 |
| Cash, cash equivalents and restricted cash at beginning of period | 121,100 | 109,926 | 89,222 | - |
| Cash, cash equivalents and restricted cash at end of period | 133,315 | 121,100 | 109,926 | - |
Rimini Street, Inc. (RMNI)
Rimini Street, Inc. (RMNI)